Sage Therapeutics, Inc. Selling, General and Administrative Expense
Sage Therapeutics, Inc. reported Selling, General and Administrative Expense of $62.00 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2025-07-30
- Sage Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2025-06-30 was $62.00M, a 10.74% increase year-over-year.
- Sage Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2025-03-31 was $57.59M, a 9.54% increase year-over-year.
- Sage Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2024-12-31 was $54.65M, a 0.84% decline year-over-year.
- Sage Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2024-09-30 was $53.22M, a 31.89% decline year-over-year.
- Sage Therapeutics, Inc. selling, general and administrative expense for fiscal 2024 was $216.42M, a 21.17% decline from fiscal 2023.
- Sage Therapeutics, Inc. selling, general and administrative expense for fiscal 2023 was $274.52M, a 20.56% increase from fiscal 2022.
- Sage Therapeutics, Inc. selling, general and administrative expense for fiscal 2022 was $227.70M, a 24.09% increase from fiscal 2021.
- Sage Therapeutics, Inc. selling, general and administrative expense for fiscal 2021 was $183.50M, a 6.83% decline from fiscal 2020.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2025-06-30 | $62.00M 10-Q · filed 2025-07-30 | $119.59M 10-Q · filed 2025-07-30 | $174.23M derived: sum of 3 quarters · filed 2025-07-30 | $227.45M derived: sum of 4 quarters · filed 2025-07-30 |
| 2025-03-31 | $57.59M 10-Q · filed 2025-04-29 | $112.24M derived: sum of 2 quarters · filed 2025-04-29 | $165.46M derived: sum of 3 quarters · filed 2025-04-29 | $221.44M derived: sum of 4 quarters · filed 2025-07-30 |
| 2024-12-31 | $54.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $107.86M derived: sum of 2 quarters · filed 2025-02-11 | $163.85M derived: sum of 3 quarters · filed 2025-07-30 | $216.42M 10-K · filed 2025-02-11 |
| 2024-09-30 | $53.22M 10-Q · filed 2024-10-29 | $109.20M derived: sum of 2 quarters · filed 2025-07-30 | $161.78M 10-Q · filed 2024-10-29 | $216.88M derived: sum of 4 quarters · filed 2025-07-30 |
| 2024-06-30 | $55.98M 10-Q · filed 2025-07-30 | $108.56M 10-Q · filed 2025-07-30 | $163.67M derived: sum of 3 quarters · filed 2025-07-30 | $241.81M derived: sum of 4 quarters · filed 2025-07-30 |
| 2024-03-31 | $52.57M 10-Q · filed 2025-04-29 | $107.68M derived: sum of 2 quarters · filed 2025-04-29 | $185.82M derived: sum of 3 quarters · filed 2025-04-29 | $261.39M derived: sum of 4 quarters · filed 2025-04-29 |
| 2023-12-31 | $55.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $133.25M derived: sum of 2 quarters · filed 2025-02-11 | $208.82M derived: sum of 3 quarters · filed 2025-02-11 | $274.52M 10-K · filed 2025-02-11 |
| 2023-09-30 | $78.14M 10-Q · filed 2024-10-29 | $153.71M derived: sum of 2 quarters · filed 2024-10-29 | $219.41M 10-Q · filed 2024-10-29 | $286.74M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | $75.56M 10-Q · filed 2024-07-31 | $141.27M 10-Q · filed 2024-07-31 | $208.60M derived: sum of 3 quarters · filed 2025-02-11 | $270.08M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $65.71M 10-Q · filed 2024-04-25 | $133.04M derived: sum of 2 quarters · filed 2025-02-11 | $194.52M derived: sum of 3 quarters · filed 2025-02-11 | $246.93M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | $67.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $128.81M derived: sum of 2 quarters · filed 2025-02-11 | $181.22M derived: sum of 3 quarters · filed 2025-02-11 | $227.70M 10-K · filed 2025-02-11 |
| 2022-09-30 | $61.48M 10-Q · filed 2023-11-07 | $113.89M derived: sum of 2 quarters · filed 2023-11-07 | $160.37M 10-Q · filed 2023-11-07 | $211.97M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $52.41M 10-Q · filed 2023-08-07 | $98.89M 10-Q · filed 2023-08-07 | $150.49M derived: sum of 3 quarters · filed 2024-02-14 | $199.19M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $46.48M 10-Q · filed 2023-05-02 | $98.08M derived: sum of 2 quarters · filed 2024-02-14 | $146.78M derived: sum of 3 quarters · filed 2024-02-14 | $190.13M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $51.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $100.31M derived: sum of 2 quarters · filed 2024-02-14 | $143.65M derived: sum of 3 quarters · filed 2024-02-14 | $183.50M 10-K · filed 2024-02-14 |
| 2021-09-30 | $48.71M 10-Q · filed 2022-11-08 | $92.05M derived: sum of 2 quarters · filed 2022-11-08 | $131.90M 10-Q · filed 2022-11-08 | $185.40M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $43.35M 10-Q · filed 2022-08-02 | $83.19M 10-Q · filed 2022-08-02 | $136.69M derived: sum of 3 quarters · filed 2023-02-16 | $171.79M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $39.85M 10-Q · filed 2022-05-03 | $93.34M derived: sum of 2 quarters · filed 2023-02-16 | $128.44M derived: sum of 3 quarters · filed 2023-02-16 | $166.67M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $53.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $88.60M derived: sum of 2 quarters · filed 2023-02-16 | $126.82M derived: sum of 3 quarters · filed 2023-02-16 | $196.95M 10-K · filed 2023-02-16 |
| 2020-09-30 | $35.10M 10-Q · filed 2021-11-02 | $73.32M derived: sum of 2 quarters · filed 2021-11-02 | $143.45M 10-Q · filed 2021-11-02 | $228.58M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $38.22M 10-Q · filed 2021-08-03 | $108.36M 10-Q · filed 2021-08-03 | $193.48M derived: sum of 3 quarters · filed 2022-02-24 | $281.99M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $70.13M 10-Q · filed 2021-05-04 | $155.26M derived: sum of 2 quarters · filed 2022-02-24 | $243.76M derived: sum of 3 quarters · filed 2022-02-24 | $331.99M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $85.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $173.63M derived: sum of 2 quarters · filed 2022-02-24 | $261.86M derived: sum of 3 quarters · filed 2022-02-24 | $345.78M 10-K · filed 2022-02-24 |
| 2019-09-30 | $88.50M 10-Q · filed 2020-11-05 | $176.73M derived: sum of 2 quarters · filed 2020-11-05 | $260.65M 10-Q · filed 2020-11-05 | $336.34M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $88.23M 10-Q · filed 2020-08-10 | $172.15M 10-Q · filed 2020-08-10 | $247.84M derived: sum of 3 quarters · filed 2021-02-24 | $301.53M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $83.92M 10-Q · filed 2020-05-07 | $159.61M derived: sum of 2 quarters · filed 2021-02-24 | $213.31M derived: sum of 3 quarters · filed 2021-02-24 | $256.47M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $75.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $129.39M derived: sum of 2 quarters · filed 2021-02-24 | $172.56M derived: sum of 3 quarters · filed 2021-02-24 | $201.40M 10-K · filed 2021-02-24 |
| 2018-09-30 | $53.69M 10-Q · filed 2019-11-12 | $96.86M derived: sum of 2 quarters · filed 2019-11-12 | $125.71M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $43.17M 10-Q · filed 2019-08-06 | $72.02M 10-Q · filed 2019-08-06 | ||
| 2017-12-31 | $62.88M 10-K · filed 2020-02-27 |